Chromax

Nutrition 21 is a biotechnology company focused on the development and commercialization of clinically substantiated ingredients for the dietary supplement, functional food, and beverage markets. The company is best known for its flagship product, Chromax, a highly bioavailable form of chromium picolinate that has been extensively studied for its role in insulin sensitization and glucose metabolism. Beyond metabolic health, Nutrition 21's portfolio includes ingredients targeting cognitive function, sports nutrition, and cardiovascular health. The company emphasizes rigorous clinical research, holding numerous patents and self-affirmed Generally Recognized as Safe (GRAS) status for its key products. Nutrition 21 operates as a subsidiary of Everwell Health Solutions, continuing to innovate in the intersection of nutrition and pharmaceutical-grade science.